W Preidel1, S Saeger, I von Lucadou
1Siemens AG, Corporate Research and Development, Erlangen, Germany.
A novel electrocatalytic sensor enables continuous glucose monitoring in blood. This implantable device demonstrated reliable performance for over two months in an in-vivo sheep study.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: